Dr. Stephen Weber Pioneers Safer, More Comfortable Approach to Facial Cosmetic Surgery With Exclusive In-Office Sedation
A Game-Changing Alternative to General Anesthesia
DENVER, COLORADO / ACCESS Newswire / April 18, 2025 / Dr. Stephen Weber is transforming the surgical experience with his exclusive in-office sedation technique, offering patients a safer, more comfortable and more cost-effective alternative to general anesthesia.
Through years of refinement, Dr. Weber has created a pill-based sedation method that is combined with a specialized, dilute lidocaine numbing solution. This combination ensures patients remain relaxed and pain-free throughout their procedures while avoiding the risks, discomfort, expense and prolonged recovery commonly associated with general anesthesia and other deeper anesthesia techniques.
While Dr. Weber's groundbreaking technique is highly effective for facelifts, neck lifts, liposuction, cheek and chin implants, eyelid surgery, facial implants, fat transfer and ear pinning surgery, it is not suitable for more invasive procedures such as brow lifts or rhinoplasty, which still require traditional anesthesia in a surgical setting. In addition, Dr. Weber maintains ambulatory surgery center and local hospital privileges to accommodate surgery for patients that prefer the traditional general anesthetic approach to his portfolio of facial cosmetic surgery procedures.
Convenience, Cost Savings, and Faster Recovery
By performing procedures in his state-of-the-art office surgery suite, Dr. Weber eliminates the need for a separate ambulatory surgical center, reducing risk, cost and logistical challenges for his patients. Traditional hospital-based surgeries often require additional fees, extended recovery times and unpleasant side effects such as nausea and grogginess from general anesthesia. Dr. Weber's in-office oral sedation technique removes these concerns, offering a streamlined, personalized and more convenient experience.
'Patients love the fact that they can undergo procedures like facelift, neck lift, facial implant procedures, and eyelid surgery in a familiar, private setting,' says Dr. Weber.' They wake up feeling refreshed, without the hangover effect that general anesthesia can cause.'
Dr. Stephen Weber Recognized as a Castle Connolly Top Doctor for 2025
Dr. Stephen Weber, a distinguished Facial Plastic Surgeon, is honored as a Castle Connolly Top Doctor for 2025, a prestigious recognition awarded to the nation's most respected physicians. This accolade highlights Dr. Weber's unwavering commitment to excellence in facial plastic surgery, patient care and surgical innovation. With extensive training and over 15 years of experience, he has earned a reputation for delivering outstanding aesthetic results and pioneering advanced surgical techniques. This and more sets Dr. Stephen Weber apart as a premier cosmetic surgeon, serving patients both from within Denver and abroad.
The Future of Facial Surgery in Colorado
Dr. Weber's commitment to patient safety and comfort has led to a growing number of patients choosing in-office sedation for their procedures. Currently, over 95% of his surgical patients opt for this approach, drawn to its numerous benefits, including:
Dr. Weber is one of only a handful of board-certified Facial Plastic Surgeons worldwide to offer this level of in-office surgical care and is the only Facial Plastic Surgeon in Colorado doing so. Patients say his innovative approach has redefined their comfort, safety and accessibility, making facial cosmetic surgery more convenient than ever.
Contact Information
Dr. Steven Weber
Plastic Surgeon
720-738-4443
SOURCE: Weber Facial Plastic Surgery
press release
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
How Will Quantum Technologies Transform the $9.8 Trillion Global Healthcare Sector?
A recent publication by quantum researcher Ali Karakuş draws the attention of the medical industry. BERLIN, DE / / June 5, 2025 / Quantum researcher Ali Karakuş has published a groundbreaking scientific paper that challenges the foundations of modern medicine and proposes a bold new perspective on health. The study introduces a next-generation medical model based on quantum sensors, ethical artificial intelligence, and resonance-based diagnostics-aiming to redefine our understanding of illness and healing. Global healthcare expenditures now exceed $9.8 trillion per year. Yet, despite this enormous financial investment, chronic illnesses, mental health disorders, and stress-related conditions are on the rise. According to Karakuş, the problem is not technological scarcity but the loss of harmonic alignment between humans, nature, and their own bodies. "We measure numbers but fail to listen to frequencies," says Karakuş. "We treat symptoms, yet overlook resonance breakdowns. The body must no longer be viewed as matter alone, but as a field of waves and energy." From Symptom Suppression to Resonance Restoration At the heart of the study is a quantum-sensor-based device in development that analyzes brainwaves, heart rate variability (HRV), vagus nerve activity, microbiome signals, and ethical resonance scores. All of this data is then processed by an ethical AI engine called Zulficore, producing a holistic and personalized feedback loop. A New Question for Medicine: "What's wrong?" or "What's out of tune?" The system designed by SlientWing integrates multiple disciplines including quantum biology, neuroscience, biomimetics, ecological AI, and ethics-based algorithms. The core question is shifting: Not "What disease do you have?" But "What frequency is disturbed? Which resonance with nature is lost?" Launch Timeline The beta version of the SlientWing device is expected to be field-tested by late 2026, with full-scale production and market launch scheduled for 2027. Manufacturing will be centered in Berlin and Thrace. Contact Information Ali Karakus Founderali@ SOURCE: Neuroscience & Quantum Researcher Ali Karakus View the original press release on ACCESS Newswire Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Indianapolis Star
7 hours ago
- Indianapolis Star
New to The Street Signs National Media Agreement with NRx Pharmaceuticals for 12-Part Broadcast Series Across TV, Digital, and Outdoor Platforms
NEW YORK CITY, NEW YORK / ACCESS Newswire New to The Street, the nation's leading multi-platform financial news show, today announced it has signed a 12-part media partnership with NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), a clinical-stage biopharmaceutical company focused on life-saving therapies for patients with suicidal depression, PTSD, and chronic pain. The partnership will feature monthly televised interviews with NRx CEO Dr. Jonathan Javitt, providing updates from the front lines of biotech innovation. As part of the comprehensive campaign, New to The Street will also produce earned media placements on ABC, NBC, and CBS affiliates, a full suite of nationally aired TV commercials, and premium outdoor billboard exposure in Times Square and throughout the NYC Financial District. 'Our mission has always been to save lives with science,' said Jonathan Javitt, MD, MPH, Founder and CEO of NRx Pharmaceuticals. 'Partnering with New to The Street enables us to share the life-saving potential of NRX-101 and our broader pipeline with a national audience, at a pivotal moment in our regulatory and commercial path.' 'We are proud to bring NRX's critical work to our global audience,' said Vince Caruso, Co-Founder and CEO of New to The Street. 'This series will spotlight a company on the front lines of neuroscience and public health, and exemplifies our commitment to covering stories that matter-with scale, credibility, and impact.' The series begins airing later this month on Fox Business and Bloomberg Television as sponsored programming, reaching more than 245 million homes weekly across the U.S. and Middle East. Episodes will also stream on New to The Street's YouTube channel, which now exceeds 2.5 million subscribers, and be supported by billboard takeovers in Times Square and full media amplification through the NewsOut™ and platforms. About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals (NASDAQ: NRXP) is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for treating central nervous system disorders. Its lead investigational drug, NRX-101, has been granted FDA Breakthrough Therapy and Fast Track Designation for suicidal bipolar depression. The company is also pursuing accelerated approval for preservative-free IV ketamine (NRX-100) and advancing additional treatments for PTSD, chronic pain, and UTIs. Learn more at About New to The Street New to The Street is a leading branded content TV series that features innovative public and private companies on national television, including Fox Business and Bloomberg Television. With more than 2.52 million YouTube subscribers, a reach of 245 million TV households, and a powerful outdoor media footprint, the platform offers unmatched exposure across digital, television, and out-of-home channels. Learn more at SOURCE: New To The Street View the original press release on ACCESS Newswire
New York Times
13 hours ago
- New York Times
‘And So It Goes' Traces Billy Joel's Dramatic Early Days: 5 Takeaways
The Tribeca Festival's opening-night premiere of the upcoming HBO documentary 'Billy Joel: And So It Goes' was marked, in part, by the absence of Billy Joel himself. Late last month, the musician announced that he was canceling all of his upcoming concerts because of a brain disorder called normal pressure hydrocephalus, which has led to problems with his hearing, vision and balance. After Robert De Niro called Joel 'the poet laureate of New York' and helped introduce the film with a dramatic reading of some of his lyrics ('He works at Mr. Cacciatore's down on Sullivan Street,' he intoned), one of the film's co-directors, Susan Lacy, told the Beacon Theater audience that Joel sent his greetings — with typical wry humor: 'In fact, he said, 'Getting old sucks, but it's still preferable to getting cremated.'' The audience roared with laughter. On a note of encouragement, Lacy said Joel 'will be back.' The crowd broke out into applause throughout the screening, which included just the first part of the two-part film. It still ran nearly two and a half hours as it covered Joel's childhood and rise to fame through his infamous 1982 motorcycle accident. (To put that in perspective: It doesn't get to the writing of 'Uptown Girl.' No Christie Brinkley yet.) There are pictures and footage of early Joel performances and stories about the surprisingly robust Long Island rock scene of the 1960s. But 'Part One' is largely an intimate portrait of Joel's relationship with his first wife, Elizabeth Weber, who would eventually become his manager, and it elevates her to a starring role in his life. It also features a host of stories about the making of some of his best-known songs, and tidbits about his Long Island obstinance. Here's some of what we learned. As Joel's relationship with Weber first foundered, he attempted suicide twice. Joel and Weber's relationship began in dramatic fashion: She was married to Jon Small, Joel's early bandmate, and had a son with him. Joel and Small first played together in a group named the Hassles, then broke off to start a Led Zeppelin-inspired metal outfit called Attila. (An album cover shoot featuring a longhaired Joel standing amid sides of raw beef, wearing fur, is something to behold.) Eventually, Joel fell in love with Weber, but when a guilt-ridden Joel shared his feelings with Small, he got punched in the nose and Weber left. Despondent, Joel overdosed on pills and was in a coma for days. His sister, Judy Molinari, who had provided the pills to help him sleep, recounts her guilt onscreen. 'I felt that I killed him,' she says. Joel drank a bottle of furniture polish in another attempt on his life. After moving back into his mother's house, he checked into an observation ward where his own struggles were put into perspective. From there he started to channel his feelings into music, and the songs that he wrote as a result of the experience would become his first solo album, 'Cold Spring Harbor.' After about a year, Weber re-entered his life. Want all of The Times? Subscribe.
